Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

AbCellera Biologics Inc.

NASDAQ: ABCL · Life Sciences · 4 alerts · CIK 1703057

Share price
$11.12Close, Nov 16
Market cap
$3.63B
Shares outstanding
326.62MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All AbCellera Biologics Inc. filings on SEC EDGAR ↗

12:41 PM ET Form 4
Insider Buying

AbCellera Biologics CFO Andrew Booth Buys $97.4K of Stock

Andrew Booth, CFO, bought 8,600 shares of AbCellera Biologics Inc. at $11.33 a share, worth $97.4K in total on Nov 13, 2026. Shares held after the trade: 491,400 (+1.8%).

Value
$97.4K
Shares
8,600
Price
$11.33
Role
CFO
Holding change
+1.8%
Trade date
Nov 13, 2026
1:15 PM ET Form 4
Insider Buying

AbCellera Biologics Insider Thermopylae Holdings Ltd. Buys $699K of Stock

Thermopylae Holdings Ltd. bought 60,565 shares of AbCellera Biologics Inc. at $11.54 a share, worth $699K in total on Nov 12, 2026. Shares held after the trade: 56,194,662 (+0.1%).

Value
$699K
Shares
60,565
Price
$11.54
Holding change
+0.1%
Trade date
Nov 12, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.